The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer
Open accessAbstract
Deletion of chromosome 6q14-q22 is common in multiple human cancers including prostate cancer, and chromosome 6 transferred into cancer cells induces senescence and reduces cell growth, tumorigenicity and metastasis, indicating the existence of one or more tumor-suppressor genes in 6q. To identify the 6q tumor-suppressor gene, we first narrowed the common region of deletion to a 2.5 Mb interval at 6q14-15. Of the 11 genes located in this minimal deletion region and expressed in normal prostates, only snoRNA U50 was mutated, demonstrated transcriptional downregulation and inhibited colony formation in prostate cancer cells. The mutation, a homozygous 2 bp (TT) deletion, was found in two of 30 prostate cancer cell lines/xenografts and nine of 89 localized prostate cancers (eleven of 119 or 9% cancers). Two of 89 (2%) patients with prostate cancer also showed the same mutation in their germline DNA, but none of 104 cancer-free control men did. The homozygous deletion abolished U50 function in a colony formation assay. Analysis of 1371 prostate cancer cases and 1371 matched control men from a case-control study nested in a prospective cohort showed that, although a germline heterozygous genotype of the deletion was detected in both patients and controls at similar frequencies, the homozygosity of the deletion was significantly associated with clinically significant prostate cancer (odds ratio 2.9; 95% confidence interval 1.17-7.21). These findings establish snoRNA U50 as a reasonable candidate for the 6q tumor-suppressor gene in prostate cancer and likely in other types of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
AAV vector integration sites in mouse hepatocellular carcinoma
Donsante, A., Miller, D. G., Li, Y., Vogler, C., Brunt, E. M., Russell, D. W., & Sands, M. S. (2007) · Science · doi:10.1126/science.1142658 · Cited by 662
Cavaillé, J., Buiting, K., Kiefmann, M., Lalande, M., Brannan, C. I., Horsthemke, B., Bachellerie, J.-P., Brosius, J., & Hüttenhofer, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250426397 · Cited by 601
Cited by
Non-coding RNAs in human disease
Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer
Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F., & Williams, G. T. (2009) · Oncogene · doi:10.1038/onc.2008.373 · Cited by 775
Amaral, P. P., & Mattick, J. S. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9136-7 · Cited by 480
Deep intronic mutations and human disease
Vaz-Drago, R., Custódio, N., & Carmo-Fonseca, M. (2017) · Human Genetics · doi:10.1007/s00439-017-1809-4 · Cited by 439
Are snoRNAs and snoRNA host genes new players in cancer?
Williams, G. T., & Farzaneh, F. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3195 · Cited by 362
Targeting epigenetic regulators to overcome drug resistance in cancers
Wang, N., Ma, T., & Yu, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01341-7 · Cited by 311
Novel classes of non-coding RNAs and cancer
Sana, J., Faltejskova, P., Svoboda, M., & Slaby, O. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-103 · Cited by 304
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
Liao, J., Yu, L., Mei, Y., Guarnera, M., Shen, J., Li, R., Liu, Z., & Jiang, F. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-198 · Cited by 293
“Recently, a homozygous 2 bp (TT) deletion in snoRNA U50 was discovered in prostate cancer cell lines and localized prostate tumor tissues, while heterozygous genotype of the deletion occurred more frequently in women with breast cancer [22,23].”
BackgroundDiagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer
Martens-Uzunova, E. S., Jalava, S. E., Dits, N. F., van Leenders, G. J. L. H., Møller, S., Trapman, J., Bangma, C. H., Litman, T., Visakorpi, T., & Jenster, G. (2012) · Oncogene · doi:10.1038/onc.2011.304 · Cited by 271
Small Nucleolar RNAs: Insight Into Their Function in Cancer
Liang, J., Wen, J., Huang, Z., Chen, X.-P., Zhang, B.-X., & Chu, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00587 · Cited by 269
Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis
Mei, Y.-P., Liao, J.-P., Shen, J., Yu, L., Liu, B.-L., Liu, L., Li, R.-Y., Ji, L., Dorsey, S. G., Jiang, Z.-R., et al. (2012) · Oncogene · doi:10.1038/onc.2011.449 · Cited by 256
Diederichs, S., Bartsch, L., Berkmann, J. C., Fröse, K., Heitmann, J., Hoppe, C., Iggena, D., Jazmati, D., Karschnia, P., Linsenmeier, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506055 · Cited by 253
Regulatory role of small nucleolar RNAs in human diseases
Stepanov, G. A., Filippova, J. A., Komissarov, A. B., Kuligina, E. V., Richter, V. A., & Semenov, D. V. (2015) · BioMed Research International · doi:10.1155/2015/206849 · Cited by 154
“Themutation was detected with diagnostically significant frequencies in blood cells of males with prostate cancer and females with breast cancer [57, 58].”
BackgroundRajpathak, S. N., Vellarikkal, S. K., Patowary, A., Scaria, V., Sivasubbu, S., & Deobagkar, D. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100076 · Cited by 51
“Reduced expression of SNHG5 has been shown in breast and prostate cancer [69–72].”
BackgroundSmall nucleolar RNA and its potential role in breast cancer – A comprehensive review
Dsouza, V. L., Adiga, D., Sriharikrishnaa, S., Suresh, P. S., Chatterjee, A., & Kabekkodu, S. P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188501 · Cited by 48
Metadata
- Authors
- Dong, X.-Y., Rodriguez, C., Guo, P., Sun, X., Talbot, J. T., Zhou, W., Petros, J., Li, Q., Vessella, R. L., Kibel, A. S., Stevens, V. L., Calle, E. E., & Dong, J.-T.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-07
- Volume
- 17
- Issue
- 7
- Pages
- 1031-1042
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2133281227
- Cited by
- 200
- References
- 3
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.